Skip to main content

Table 1 Patients characteristic

From: KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

  Number of cases Age ± SD
(range)
Tumor grade [41]
(WHO-UISP2011)
Tumor stage [32]
pTNM
Cases 70 64.21 ± 11.24
(29–91)
G1 = 20
G2 = 26
G3 = 24
Stage 1 = 35Stage 2 = 16Stage 3 = 16Stage 4 = 1
Male 46 64.63 ± 11,84
(29–91)
G1 = 15
G2 = 16
G3 = 15
Stage I = 23Stage II = 9Stage III =12Stage IV = 1
Female 24 63.42 ± 10.18
(45–79)
G1 = 5
G2 = 10
G3 = 9
Stage I = 12Stage II = 7Stage III = 4Stage IV = 0